top of page
Search
Writer's pictureKate Shaw

A cost savings of $4926 per patient!!




the overall cost savings

Sensitivity analyses estimated that costs of pharmacogenomic testing would be offset within about 2 years of implementation.

CMAJ 2023 November 14;195:E1499-1508. doi: 10.1503/cmaj.22178



over the 20-year time horizon, or a cost savings of $4926 per patient.

12 views0 comments

Recent Posts

See All

Psychiatry, Neurology and CYP2D6

The 45 drug products that are FDA-approved for use in neurology and psychiatry that contain pharmacogenomic information in their drug...

CME available from the AMA MedHub on PGx

Recognize the full potential of genomics and precision medicine in health and health care. Understand the opportunities of genomics and...

Update on Applications in Bipolar Disorder

The authors investigate where CYP2C19 polymorphisms are associated with antidepressant treatment patterns and the risk of mania when...

Comments


bottom of page